Chu De Quebec-universite Laval
Clinical trials sponsored by Chu De Quebec-universite Laval, explained in plain language.
-
Custom skin patch offers hope for rare blistering condition
Disease control OngoingThis study tests a lab-made skin substitute on one patient with dystrophic epidermolysis bullosa, a rare disease causing fragile skin and chronic wounds. The goal is to see if the graft can reduce wound size and pain. It is an early-stage, single-patient trial, not a cure.
Phase: EARLY_PHASE1 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Starving cancer cells: could cholesterol drugs slow pancreatic tumors?
Disease control OngoingThis early study tests whether adding three cholesterol-lowering drugs (atorvastatin, ezetimibe, and evolocumab) to standard chemotherapy can slow or stop pancreatic cancer growth. Cancer cells need lots of cholesterol to grow, and this approach aims to starve them. The trial inc…
Phase: EARLY_PHASE1 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Fish oil may delay hormone therapy in prostate cancer patients
Disease control OngoingThis study tests whether a daily high-dose omega-3 supplement (fish oil) can slow the rise of PSA levels in men whose prostate cancer has returned after initial treatment. About 40 men with a rising PSA but no spread will take either the supplement or a placebo for one year. The …
Phase: PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Fish oil pills could help fight prostate cancer, new study hints
Disease control OngoingThis phase 2 trial tests whether taking omega-3 (EPA) supplements can reduce inflammation and slow cancer cell growth in men with high-risk prostate cancer who choose surgery. 130 participants will take either EPA capsules or a placebo for 14 months, starting before surgery. Rese…
Phase: PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Can a shorter radiation course for prostate cancer be just as safe?
Disease control TerminatedThis phase 3 trial compares a new, shorter course of radiation (ultra-hypofractionated) to the standard longer course for men with prostate cancer that has spread to lymph nodes. Both groups also receive a brachytherapy boost and hormone therapy. The study aims to see if the shor…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated Jun 26, 2026 16:07 UTC
-
New scan spots prostate cancer that standard tests miss
Diagnosis OngoingThis study tests a special PET scan (18F-DCFPyL) to see if it can find prostate cancer spread that standard scans miss. Fifty men with castration-resistant prostate cancer starting enzalutamide will get the new scan. The goal is to better detect and monitor metastases, which coul…
Phase: PHASE2 • Sponsor: CHU de Quebec-Universite Laval • Aim: Diagnosis
Last updated Jun 27, 2026 08:06 UTC
-
Can Omega-3s and a prostate drug keep Low-Risk cancer in check?
Prevention OngoingThis study looks at whether eating more omega-3 fatty acids (like those in fish oil) and taking a drug called dutasteride can slow the growth of low-risk prostate cancer. The 120 participants are men on active surveillance, meaning their cancer is being watched rather than treate…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Prevention
Last updated Jun 27, 2026 07:59 UTC
-
Early diet coaching may cut gestational diabetes risk in at-risk moms
Prevention OngoingThis study tests whether starting nutritional counseling early in pregnancy can improve blood sugar control in women at risk for gestational diabetes. 150 pregnant women will receive either standard care or one-on-one sessions with a dietitian, plus videos and phone support. The …
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Prevention
Last updated Jun 26, 2026 14:59 UTC
-
Could a drug combo during surgery speed up recovery?
Symptom relief OngoingThis pilot study tests whether giving dexmedetomidine and lidocaine during major non-cardiac surgery can help patients recover faster and with less pain. About 100 adults having elective surgery will be randomly assigned to receive one of these drugs or standard care. The main go…
Phase: NA • Sponsor: CHU de Quebec-Universite Laval • Aim: Symptom relief
Last updated Jul 02, 2026 05:00 UTC
-
Prostate cancer risk: could a simple blood test predict it?
Knowledge-focused OngoingThis study is looking at how things like diet, physical activity, and other lifestyle habits might affect a man's risk of getting prostate cancer. Researchers are studying more than 2000 men who are at higher risk to find biological markers in the blood that could help predict ri…
Sponsor: CHU de Quebec-Universite Laval • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC